Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple ...

Atrium Health Foundation has received more than $4 million in grant funding from The Duke Endowment to expand its digital health and education initiatives, including a virtual nursing program, ...

Dr. Zuraw led clinical development of telitacicept across MG, Sjögren's, SLE, and RA at RemeGen, resulting in multiple regulatory approvals in China; brings deep U.S. and global development experience ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference Plus will also host an ...

Organon & Co. (NYSE:OGN) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 2, Organon & Co.

New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly- ...

U.S. metropolitan areas have been identified as hot spots for hiring, job listings and talent migration, according to LinkedIn News’ “Cities on the Rise” list. Hospitals and health systems are among ...

With a deep background in research and years of senior care experience, Shadi Gholizadeh, PhD, uses her clinical know-how to drive TheKey to operational excellence.

The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...

A key House committee has blocked a bipartisan amendment to a spending bill that would have given the Department of Defense ...

Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...